Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Kodiak Sciences Stock Quote

Kodiak Sciences (NASDAQ: KOD)

Price as of July 17, 2024, 4:00 p.m. ET

Kodiak Sciences Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
KOD -56.69% -79.31% -27.03% -68%
S&P +25.30% +89.21% +13.60% +95%

Kodiak Sciences Company Info

Kodiak's portfolio of candidate eye treatments centers on its innovative antibody biopolymer conjugate platform.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.